🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Neoplasm Malignant Female

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer NCT06938724Phase 21 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: Omission of local therapies 18F-FDG PET/CT Imaging for Breast Cancer NCT05730608NA1 site📍 Drammen Vestre Viken Hospital Trust · Tests: 18F-FDG PET/CT Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors NCT06666270Phase 12 sites📍 Zhengzhou📍 Shanghai Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · Tests: SYN818 TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients NCT05535192NA4 sites📍 Boston📍 Cleveland📍 Pittsburgh Dana-Farber Cancer Institute · Tests: THRIVE, Health Education Support Program High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study NCT03342625NA1 site📍 Bordeaux Institut Bergonié · Tests: High Instensity Focused Ultrasound Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE) NCT06445738NA9 sites📍 San Francisco📍 Houston📍 Camperdown Breast Cancer Trials, Australia and New Zealand · Tests: Arm A: Radiotherapy Omission, Arm B: Standard Treatment A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites📍 Duarte📍 Los Angeles📍 San Francisco Nurix Therapeutics, Inc. · Tests: NX-1607, Paclitaxel A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients. NCT05585476NA1 site📍 Madrid Instituto de Investigación Sanitaria de la Fundación Jiméne… · Tests: C02 microablative laser, Regenerative topical treatment ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health NCT07505797n/a2 sites📍 Sacramento📍 Cypress iSono Health, Inc. · Tests: ATUSA 3D Automated Breast Ultrasound System EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection NCT06291896NA10 sites📍 Genova📍 Foligno📍 Trieste Umbria Bioengineering Technologies · Tests: MammoWave Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT NCT05314114NA1 site📍 Beijing Peking University · Tests: No axillary surgery The MASTER Study (MAmmary Cancer STatin ER Positive Study) NCT04601116Phase 31 site📍 Aarhus Aarhus University Hospital · Tests: Atorvastatin 80 Mg Oral Tablet, Placebo oral tablet GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors NCT06265025Phase 1, Phase 24 sites📍 Goyang-si📍 Seoul📍 Seoul GeneMedicine Co., Ltd. · Tests: GM103 (Part A), GM103 (Part B), GM103 and Pembrolizumab (Part C) A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites📍 Duarte📍 La Jolla📍 Los Angeles Eli Lilly and Company · Tests: LY4052031, Pembrolizumab Cognitive Rehabilitation Following Breast Cancer Treatment NCT06545045NA1 site📍 Columbia University of Missouri-Columbia · Tests: Metacognitive Strategy Training (MCST), Inactive Control Group Comprehensive Outcomes for After Cancer Health NCT05349227NA7 sites📍 Gainesville📍 Boston📍 Omaha Pack Health · Tests: Digital Health Coaching Program, Fitbit ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer NCT07198724Phase 1, Phase 21 site📍 Boston Kristina A. Fanucci · Tests: Elacestrant, Trastuzumab Deruxtecan Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients NCT05452213Phase 452 sites📍 Erlangen📍 Mainz📍 Bottrop Institut fuer Frauengesundheit · Tests: Ribociclib Multiple Risk Factor Intervention Trial in Breast Cancer Survivors NCT06454864NA1 site📍 Toronto University of Toronto · Tests: Guidelines-based healthy eating, Guidelines-based physical activity, Stretching exercise Distance-Based Exercise to Preserve Function and Prevent Disability NCT07059884NA23 sites📍 Dublin📍 Fremont📍 Fresno Alliance for Clinical Trials in Oncology · Tests: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Exercise Intervention, Accelerometry Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer NCT03177902n/a1 site📍 Bengbu The First Affiliated Hospital of Bengbu Medical University · Tests: Chemotherapy Supporting Health Including Endocrine Treatment for Long Duration NCT07482384NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: SHIELD portal A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies NCT04503265Phase 1, Phase 24 sites📍 Los Angeles📍 Baltimore📍 Nashville AtlasMedx, Incorporated · Tests: AMXI-5001:Dose Escalation Phase I, AMXI-5001:Dose Expansion Phase II Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients NCT04038619Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Fecal Microbiota Transplantation, Loperamide Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia NCT07741435n/a1 site📍 Bogotá Centro de Tratamiento e Investigación sobre Cáncer, Luis Ca… · Tests: Methylscape DNA methylation assay GammaPod Registry and Quality of Life Nomogram NCT03562273n/a4 sites📍 Bel Air📍 Columbia📍 Glen Burnie University of Maryland, Baltimore · Tests: Quality Of Life Sizing Nomogram
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy